Mr Peter Bronnum Nielsen
Aalborg University Hospital, Aalborg (Denmark)
Time-trends of sex differences in stroke risk in atrial fibrillation: Are female patients still at higher risk today? A nationwide cohort study
Event: EHRA 2024
Topic: Epidemiology, Prognosis, Outcome
Session: Atrial fibrillation: clinical 1
Intracranial haemorrhage in patients with atrial fibrillation: we should still anticoagulate - pro
Event: ESC Congress 2023
Topic: Prevention
Session: Great Debate: preventing stroke in carotid disease and intracranial haemorrhage
Direct oral anticoagulation versus warfarin in atrial fibrillation: a nationwide cohort study of effectiveness and safety among frail patients
Event: ESC Congress 2023
Topic: Stroke in Atrial Fibrillation
Session: Stroke prediction and prevention in atrial fibrillation
Comparative effectiveness and safety of edoxaban vs warfarin in patients with atrial fibrillation: a nationwide cohort study
Event: ESC Congress 2021 - The Digital Experience
Topic: Epidemiology, Prognosis, Outcome
Session: Atrial fibrillation: risks and management
Risk of cerebrovascular events in intracerebral haemorrhage survivors with atrial fibrillation: The Danish Stroke Registry
Event: ESC Congress 2021 - The Digital Experience
Topic: Stroke in Atrial Fibrillation
Session: Congress committee e-posters choice in arrhythmias and device therapy
Risk of ischemic stroke and recurrent ICH in patients with atrial fibrillation presenting with incident ICH: an analysis from the Danish Stroke Registry
Event: ESC Congress 2020
Topic: Stroke in Atrial Fibrillation
Session: Atrial Fibrillation ePosters
Prevention of stroke in intracerebral haemorrhage survivors with atrial fibrillation (PRESTIGE-AF): a retrospective cohort study
Event: ESC Congress 2019
Topic: Cardiovascular Epidemiology
Session: Cardiovascular epidemiology and trials
Female sex is a risk modifier - not a risk factor - for stroke risk assessment in atrial fibrillation: Using a CHA2DS2-VA score rather than CHA2DS2-VASc
Event: ESC Congress 2017
Topic: Atrial fibrillation (AF)
Session: Stroke risk prediction in atrial fibrillation
Patient with a CHA2DS2VASc score of 1: what to do?
Event: ESC Congress 2017
Topic: Atrial fibrillation (AF)
Session: Stroke prevention in atrial fibrillation: the known knowns and the known unknowns
Predictive value of the HAS-BLED, ATRIA, and ORBIT bleeding risk classification in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants (NOACs)
Event: ESC Congress 2017
Topic: Atrial fibrillation (AF)
Session: Bleeding and LAA occlusion
ESC 365 is supported by
